Semax

$29.90

ACTH analogue · BDNF upregulation · neuroprotection

Specification: 10 mg / vial

Availability: Usually ships within 2 days.

SKU: SEM10 Category:
Research product information

Semax

Structured product, pathway, quality-documentation, and laboratory-handling information.

Product overview

Product
Semax
SKU
SEM10
Compound
Semax
Strength
10 mg / vial
Product format
Lyophilised peptide
Quantity per vial
10 mg
Category
Stock
Availability shown at checkout

Compound profile

Receptor or pathway
Investigated in neuro-signalling and peptide pathways
Common areas of scientific investigation
  • Neurobiology studies
  • Cognitive pathway investigation
  • Preclinical peptide signalling studies
Known status
Investigational peptide with mixed translational evidence across sources.
Important limitations of available evidence
Evidence quality and protocol consistency vary across publications and regions.

Quality documentation

COA details are published when valid batch documentation is available. No certificate is currently assigned to this SKU.

View all available certificates →

Storage and laboratory handling

Unopened storage
Store as directed by supplier and lot documentation.
Light exposure
Keep protected from direct light.
Temperature range
Apply lot-specific storage temperature controls from documentation.
Lyophilised
Yes
  • Use sterile laboratory handling.
  • Record preparation and storage conditions in study logs.

Recommended laboratory accessories

Description

Semax is a synthetic analogue of ACTH (4-7) developed in Russia. Research indicates it upregulates BDNF, enhances memory, and provides neuroprotective effects.

For research use only. Not for human consumption.

Reviews

There are no reviews yet.

Be the first to review “Semax”

Your email address will not be published. Required fields are marked *